Literature DB >> 25683732

Muscle atrophy contributes to quadriceps weakness after anterior cruciate ligament reconstruction.

Abbey C Thomas1, Edward M Wojtys2, Catherine Brandon3, Riann M Palmieri-Smith4.   

Abstract

OBJECTIVES: Quadriceps weakness persists after anterior cruciate ligament reconstruction. Muscle atrophy and activation failure may contribute. This study examined the roles of atrophy and activation failure in quadriceps weakness after anterior cruciate ligament reconstruction.
DESIGN: Case series.
METHODS: Twenty patients six months post-anterior cruciate ligament reconstruction participated. Atrophy was determined as peak quadriceps cross sectional area from magnetic resonance images. Quadriceps activation was quantified via the central activation ratio, while muscle strength was measured isometrically. All testing was performed bilaterally. Hierarchical linear regression and one-way ANOVAs were performed to examine the relation of muscle strength with activation and atrophy.
RESULTS: Cross sectional area (R(2)=0.307; p=0.011) explained more of the variance in quadriceps strength than central activation ratio (R(2)<0.001; p=0.987). Strength and cross sectional area were lower in the injured (strength: 2.03±0.51Nm/kg; cross sectional area: 68.81±17.80cm(2)) versus uninjured limb (strength: 2.89±0.81Nm/kg; cross sectional area: 81.10±21.58cm(2); p<0.001). There were no side-to-side differences in central activation ratio; however, quadriceps activation failure was present bilaterally (injured: 0.87±0.12; uninjured: 0.85±0.14; p=0.571).
CONCLUSIONS: Quadriceps cross sectional area was strongly related to muscle strength six months after anterior cruciate ligament reconstruction and substantial injured versus uninjured limb deficits were demonstrated for strength and cross sectional area. Patients may benefit from exercises aimed at improving quadriceps cross sectional area post-operatively.
Copyright © 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anterior cruciate ligament; Central activation ratio; MRI; Muscle; Strength

Mesh:

Year:  2015        PMID: 25683732      PMCID: PMC4500756          DOI: 10.1016/j.jsams.2014.12.009

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  30 in total

1.  Neuromuscular adaptations and correlates of knee functionality following ACL reconstruction.

Authors:  Adam L Bryant; Jason Kelly; Erik Hohmann
Journal:  J Orthop Res       Date:  2008-01       Impact factor: 3.494

2.  Selective atrophy of red muscle fibres in the quadriceps in long-standing knee-joint dysfunction. Injuries to the anterior cruciate ligament.

Authors:  L Edström
Journal:  J Neurol Sci       Date:  1970-12       Impact factor: 3.181

3.  Reflex inhibition of the quadriceps femoris muscle after injury or reconstruction of the anterior cruciate ligament.

Authors:  L Snyder-Mackler; P F De Luca; P R Williams; M E Eastlack; A R Bartolozzi
Journal:  J Bone Joint Surg Am       Date:  1994-04       Impact factor: 5.284

4.  Early quadriceps strength loss after total knee arthroplasty. The contributions of muscle atrophy and failure of voluntary muscle activation.

Authors:  Ryan L Mizner; Stephanie C Petterson; Jennifer E Stevens; Krista Vandenborne; Lynn Snyder-Mackler
Journal:  J Bone Joint Surg Am       Date:  2005-05       Impact factor: 5.284

5.  Effects of aging on human skeletal muscle after immobilization and retraining.

Authors:  C Suetta; L G Hvid; L Justesen; U Christensen; K Neergaard; L Simonsen; N Ortenblad; S P Magnusson; M Kjaer; P Aagaard
Journal:  J Appl Physiol (1985)       Date:  2009-08-06

6.  A mechanism for increased contractile strength of human pennate muscle in response to strength training: changes in muscle architecture.

Authors:  P Aagaard; J L Andersen; P Dyhre-Poulsen; A M Leffers; A Wagner; S P Magnusson; J Halkjaer-Kristensen; E B Simonsen
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

7.  Muscle and tendon morphology after reconstruction of the anterior cruciate ligament with autologous semitendinosus-gracilis graft.

Authors:  Glenn N Williams; Lynn Snyder-Mackler; Peter J Barrance; Michael J Axe; Thomas S Buchanan
Journal:  J Bone Joint Surg Am       Date:  2004-09       Impact factor: 5.284

8.  Correlation of remaining patellar tendon width with quadriceps strength after autogenous bone-patellar tendon-bone anterior cruciate ligament reconstruction.

Authors:  K D Shelbourne; R A Rubinstein; C D VanMeter; J R McCarroll; A C Rettig
Journal:  Am J Sports Med       Date:  1994 Nov-Dec       Impact factor: 6.202

9.  Does the patellar tendon normalize after harvesting its central third?: a prospective long-term MRI study.

Authors:  Michael Svensson; Jüri Kartus; Lars Ejerhed; Sven Lindahl; Jon Karlsson
Journal:  Am J Sports Med       Date:  2004 Jan-Feb       Impact factor: 6.202

10.  Training-induced changes in structural and mechanical properties of the patellar tendon are related to muscle hypertrophy but not to strength gains.

Authors:  O R Seynnes; R M Erskine; C N Maganaris; S Longo; E M Simoneau; J F Grosset; M V Narici
Journal:  J Appl Physiol (1985)       Date:  2009-05-28
View more
  54 in total

Review 1.  Aspects of physical medicine and rehabilitation in the treatment of deconditioned patients in the acute care setting: the role of skeletal muscle.

Authors:  Michael Quittan
Journal:  Wien Med Wochenschr       Date:  2016-01-12

2.  Contribution of Neuromuscular Factors to Quadriceps Asymmetry After Anterior Cruciate Ligament Reconstruction.

Authors:  Alexa K Johnson; Riann M Palmieri-Smith; Lindsey K Lepley
Journal:  J Athl Train       Date:  2018-04-13       Impact factor: 2.860

Review 3.  Skeletal Muscle Disuse Atrophy and the Rehabilitative Role of Protein in Recovery from Musculoskeletal Injury.

Authors:  Emily E Howard; Stefan M Pasiakos; Maya A Fussell; Nancy R Rodriguez
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

4.  Acute non-contact anterior cruciate ligament tears are associated with relatively increased vastus medialis to semimembranosus cross-sectional area ratio: a case-control retrospective MR study.

Authors:  Ged G Wieschhoff; Jacob C Mandell; Gregory J Czuczman; Violeta Nikac; Nehal Shah; Stacy E Smith
Journal:  Skeletal Radiol       Date:  2017-07-15       Impact factor: 2.199

5.  Early clinical and neuromuscular properties in patients with normal or sub-normal subjective knee function after anterior cruciate ligament reconstruction.

Authors:  Domen Stropnik; Matjaž Sajovic; Alan Kacin; Simona Pavlič-Založnik; Matej Drobnič
Journal:  Arch Orthop Trauma Surg       Date:  2020-04-08       Impact factor: 3.067

6.  Quadriceps muscle function following anterior cruciate ligament reconstruction: systemic differences in neural and morphological characteristics.

Authors:  Adam S Lepley; Dustin R Grooms; Julie P Burland; Steven M Davi; Jeffrey M Kinsella-Shaw; Lindsey K Lepley
Journal:  Exp Brain Res       Date:  2019-03-09       Impact factor: 1.972

7.  Avoid post operative bracing to reduce ACL rerupture rates.

Authors:  Arjun Ajith Naik; Bishwaranjan Das; Yogeesh D Kamat
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-26

8.  Cold shock protein RBM3 attenuates atrophy and induces hypertrophy in skeletal muscle.

Authors:  Douglas W Van Pelt; Amy L Confides; Andrew R Judge; Peter W Vanderklish; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2018-07-26       Impact factor: 2.698

9.  Quadriceps Neuromuscular and Physical Function After Anterior Cruciate Ligament Reconstruction.

Authors:  Jennifer L Hunnicutt; Michelle M McLeod; Harris S Slone; Chris M Gregory
Journal:  J Athl Train       Date:  2020-01-29       Impact factor: 2.860

10.  A Cross-sectional Examination of Quadriceps Strength, Biomechanical Function, and Functional Performance From 9 to 24 Months After Anterior Cruciate Ligament Reconstruction.

Authors:  Michael T Curran; Asheesh Bedi; Megan Kujawa; Riann Palmieri-Smith
Journal:  Am J Sports Med       Date:  2020-07-21       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.